2007
DOI: 10.1016/j.lungcan.2007.06.026
|View full text |Cite
|
Sign up to set email alerts
|

Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofluorescence bronchoscopy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
58
0
4

Year Published

2009
2009
2020
2020

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 77 publications
(62 citation statements)
references
References 34 publications
0
58
0
4
Order By: Relevance
“…Evaluation of tumor extent and tumor depth is very important to the success of PDT (6,11,13). We previously assessed the usefulness of a photodynamic diagnosis (PDD) system consisting of autofluorescence bronchoscopy SAFE-3000 (14) and NPe6 as a means of accurately defining the tumor margin before PDT (13).…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…Evaluation of tumor extent and tumor depth is very important to the success of PDT (6,11,13). We previously assessed the usefulness of a photodynamic diagnosis (PDD) system consisting of autofluorescence bronchoscopy SAFE-3000 (14) and NPe6 as a means of accurately defining the tumor margin before PDT (13).…”
mentioning
confidence: 99%
“…We previously assessed the usefulness of a photodynamic diagnosis (PDD) system consisting of autofluorescence bronchoscopy SAFE-3000 (14) and NPe6 as a means of accurately defining the tumor margin before PDT (13). Although it was difficult to clearly identify tumor extent and to accurately radiate the tumor, we were able to clearly detect red fluorescence emanating from the tumor with the PDD system before PDT, and the PDD system consisting of SAFE-3000 and NPe6 allowed more accurate assessment of the tumor margin and the quality and efficacy of PDT (13).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The thickened type is characterized by superficial lesions manifested by subtle mucosal changes on the bronchial surface, and it is the predominant type (14)(15)(16)(17). Of the 16 lesions examined in this study, 11 of them were the thickened type, 4 lesions were nodular type and 1 was the polypoid type.…”
Section: Patients' Characteristicsmentioning
confidence: 83%
“…The Japanese Lung Cancer Society classifies CLELCs on the basis of the endoscopic findings into a thickened type, polypoid type, and nodular type (14)(15)(16)(17). The thickened type is characterized by superficial lesions manifested by subtle mucosal changes on the bronchial surface, and it is the predominant type (14)(15)(16)(17).…”
Section: Patients' Characteristicsmentioning
confidence: 99%